Search

everythinglearnresearchcommunity

for

Search:↓

Linoleic acid and magnesium are key in alopecia areata progression, and tofacitinib can help by affecting their pathway.

The registry showed that tofacitinib is promising for treating hair loss in children with alopecia areata, but more research is needed.

Combining nanofat with FUE improves scar appearance and function better than FUE alone.

The neighborhood face index (NFI) accurately predicts properties of complex molecules.

NFIC helps human dental stem cells grow and become tooth-like cells.

The N gene affects the protein makeup of mouse hair.

Using facial sunscreen and moisturizer may increase the risk of frontal fibrosing alopecia.

Linoleic acid and magnesium are key in alopecia areata progression, and tofacitinib can help by affecting their pathway.

More research needed to confirm finasteride as standard treatment for FFA.

The new gel formula could improve the delivery of a hair loss treatment through the skin and might be an alternative to taking it by mouth.

Certain miRNAs might be involved in a hair loss condition called frontal fibrosing alopecia and could possibly help in its diagnosis.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Tofacitinib shows promise for treating severe hair loss in adults and teens, with many experiencing regrowth, but hair loss returns when treatment stops.

Radiation treatment causes skin fibrosis by increasing certain fibroblast subpopulations, but using a c-Jun inhibitor or fat grafting can reduce this effect.

Targeting immune pathways like JAK/STAT may help treat frontal fibrosing alopecia.

The NIPAL4 mutation c.527C>A is common in Romanian patients with autosomal recessive congenital ichthyosis.

Patients with certain FoxN1 gene mutations have severe immune issues but normal skin and hair.

Mitochondrial Complex I reduces inflammation and increases bone breakdown by affecting certain immune cells.

Tofacitinib may help treat nail dystrophy, especially when other treatments fail.

Nfib in hair follicle stem cells boosts melanocyte stem cell growth and differentiation.

New treatments for immune disorders caused by FOXN1 deficiency are promising.

Targeting NETs may help reduce fibrosis in Crohn's disease.

TNF-a may not be as involved in certain types of hair loss as previously thought.

Frontal Fibrosing Alopecia is a poorly understood condition that is hard to treat and causes distressing hair loss.

Frontal fibrosing alopecia may affect nails and could be a type of lichen planus, treatable with certain medications.

The document's conclusion cannot be provided because the content is not available.

FP-1 is a key protein in rat hair growth, active only during the growth phase.

Dietetic-led cognitive-behavioral therapy may improve treatment for adults with ARFID.

Tofacitinib helped regrow hair in most patients with severe hair loss.

Early diagnosis and combination therapy, especially with finasteride and dutasteride, are key to managing Frontal Fibrosing Alopecia effectively.